Current filters:


6776 to 6785 of 12918 results

$25 million milestone for Protalix following US approval of Elelyso


Israel-based Protalix BioTherapeutics (TASE:PLX) has received a $25 million milestone payment from global…

ElelysoFinancialPfizerPharmaceuticalProtalix BioTherapeuticsRare diseases

Lilly to increase equity position in China's Novast by $20 million


US pharma major Eli Lilly (NYSE: LLY) says it will increase of its network of manufacturing capabilities…

Asia-PacificEli LillyGenericsMergers & AcquisitionsNovast LaboratoriesPharmaceutical

More news from American Diabetes Association meeting


Ongoing news from the American Diabetes Association meeting in Philadelphia (see also The Pharma Letter…

Boehringer IngelheimDiabetesEli LillyLantusLY2605541PharmaceuticalResearchSanofi

Alkermes and J&J initiate Ph III trial of three-month Invega Sustenna


USA-based Alkermes (Nasdaq: ALKS) and partner health care giant Johnson & Johnson (NYSE: JNJ) have started…

AlkermesInvega SustennaJohnson & JohnsonNeurologicalPharmaceuticalResearch

UBICHEM Group adds new large scale manufacturing site in Hungary


Independent UK company UBICHEM Group has announced further growth of its business by adding a new manufacturing…

EuropeFinancialGenericsPharmaceuticalUBICHEM Group

US regulator puts conditions on Johnson & Johnson's proposed buy of Synthes


The US Federal Trade Commission will require health care giant Johnson & Johnson (NYSE: JNJ) to sell…

Johnson & JohnsonMergers & AcquisitionsNorth AmericaPharmaceuticalRegulationSynthes

New ruthenium-based drugs show promise for killing cancer ells


A new study by University of Kentucky, USA, researchers shows how light and strained ruthenium-based…


Genzyme files multiple sclerosis drug Lemtrada with FDA and EMA


French drug major Sanofi (Euronext: SAN) subsidiary Genzyme revealed this morning that it has submitted…

BayerBiotechnologyEuropeGenzymeLemtradaNeurologicalNorth AmericaPharmaceuticalRegulationSanofi

Forest Labs cuts FY 2013 earnings forecasts on Lexapro woes


Following the expiration of US drugmaker Forest Laboratories' (NYSE: FRX) once best-selling anxiety drug…

FinancialForest LaboratoriesGenericsLevothroidLexaproPharmaceutical

6776 to 6785 of 12918 results

Back to top